Comp-10 demonstrated superior efficacy in inhibiting the growth and colony formation of ALK-positive and MCL cells, including drug-resistant models, while sparing non-malignant cells like OVCAR3. The gene discussed is ALK; the disease is mantle cell lymphoma.